|
US5900431A
(en)
*
|
1995-03-27 |
1999-05-04 |
Sanofi |
Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
|
|
WO1998014169A1
(en)
*
|
1996-09-30 |
1998-04-09 |
Brigham & Women's Hospital |
Methods and compounds for treatment of abnormal uterine bleeding
|
|
ES2224465T3
(es)
*
|
1997-10-31 |
2005-03-01 |
Children's Medical Center Corporation |
Metodo para regular el tamaño y el crecimiento del tejido normal vascularizado.
|
|
CN100340291C
(zh)
*
|
1998-10-09 |
2007-10-03 |
路德维格癌症研究院 |
F1t4(VEGFR－3)作为肿瘤显像和抗肿瘤治疗的靶
|
|
US7141607B1
(en)
*
|
2000-03-10 |
2006-11-28 |
Insite Vision Incorporated |
Methods and compositions for treating and inhibiting retinal neovascularization
|
|
CA2497497A1
(en)
*
|
2002-09-04 |
2004-03-18 |
Proteinexpress Co., Ltd. |
Regulators for implantation
|
|
US20040266688A1
(en)
*
|
2003-05-14 |
2004-12-30 |
Nayak Nihar R |
Methods for modulating endometrium
|
|
WO2005004999A1
(en)
*
|
2003-07-14 |
2005-01-20 |
Fusion Sport International Pty Ltd |
Sports training and testing methods, apparatus and system
|
|
EP1668129B1
(en)
*
|
2003-08-29 |
2008-10-29 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the n-terminus of endostatin
|
|
US7524811B2
(en)
*
|
2003-08-29 |
2009-04-28 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the N-terminus of endostatin
|
|
CN102099491A
(zh)
*
|
2008-05-15 |
2011-06-15 |
北卡罗来纳-查佩尔山大学 |
调节血管生成的新靶标
|
|
EP2140860A1
(en)
|
2008-07-03 |
2010-01-06 |
Bayer Schering Pharma Oy |
An improved method of contraception
|
|
CN102123586A
(zh)
|
2008-07-18 |
2011-07-13 |
法弗根股份有限公司 |
治疗超重或肥胖受试者的方法
|
|
US20100159506A1
(en)
*
|
2008-07-25 |
2010-06-24 |
Cellscape Corporation |
Methods and systems for genetic analysis of fetal nucleated red blood cells
|
|
WO2010065877A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Methods of treating an overweight or obese subject
|
|
US8642650B2
(en)
|
2008-12-04 |
2014-02-04 |
Zafgen, Inc. |
Methods of treating an overweight or obese subject
|
|
KR20120083905A
(ko)
|
2009-10-09 |
2012-07-26 |
자프겐 코포레이션 |
비만의 치료에 사용하기 위한 설폰 화합물
|
|
CN102791699B
(zh)
|
2010-01-08 |
2016-04-06 |
扎夫根公司 |
烟曲霉醇型化合物和其制造和使用方法
|
|
US8815309B2
(en)
|
2010-01-08 |
2014-08-26 |
Zafgen, Inc. |
Methods of treating a subject with benign prostate hyperplasia
|
|
RU2427325C1
(ru)
*
|
2010-01-29 |
2011-08-27 |
Государственное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО АГМА Росздрава) |
Способ оценки эффективности лечения хронической плацентарной недостаточности в эксперименте
|
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
|
US20130266578A1
(en)
|
2010-04-07 |
2013-10-10 |
Thomas E. Hughes |
Methods of treating an overweight subject
|
|
CA2796744A1
(en)
|
2010-04-17 |
2011-10-20 |
Bayer Healthcare Llc |
Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
JP2013531067A
(ja)
|
2010-07-19 |
2013-08-01 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
疾病及び状態の処置及び予防のためのフルオロ置換オメガ−カルボキシアリールジフェニル尿素を用いた組み合わせ薬
|
|
CN103249735B
(zh)
|
2010-07-22 |
2016-04-06 |
扎夫根股份有限公司 |
三环化合物及其制备和使用方法
|
|
PH12013500934A1
(en)
|
2010-11-09 |
2022-10-24 |
Zafgen Inc |
Crystalline solids of a metap-2 inhibitor and methods of making and using same
|
|
BR112013013411A2
(pt)
|
2010-11-29 |
2016-09-13 |
Zafgen Inc |
tratamento de obesidade usando administração não diária de 6-0-(4-dimetilaminoetxi) cinamoil fumagilol
|
|
EP2668169B1
(en)
|
2011-01-26 |
2017-11-15 |
Zafgen, Inc. |
Tetrazole compounds and methods of making and using same
|
|
MX342257B
(es)
|
2011-03-08 |
2016-09-21 |
Zafgen Inc |
Derivados y análogos de oxaspiro [2.5] octano.
|
|
BR112013028534A2
(pt)
|
2011-05-06 |
2016-09-06 |
Zafgen Inc |
compostos tricíclicos parcialmente saturados e métodos para produção e utilização dos mesmos
|
|
AU2012253759B2
(en)
|
2011-05-06 |
2016-01-21 |
Zafgen Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
|
US9242997B2
(en)
|
2011-05-06 |
2016-01-26 |
Zafgen, Inc. |
Tricyclic pyrazole sulphonamide compunds and methods of making and using same
|
|
EP2763671A2
(en)
|
2011-10-03 |
2014-08-13 |
Zafgen, Inc. |
Methods of treating age related disorders
|
|
CA2861390A1
(en)
|
2012-01-18 |
2013-07-25 |
Zafgen, Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
|
JP2015509102A
(ja)
|
2012-01-18 |
2015-03-26 |
ザフゲン，インコーポレイテッド |
三環式スルホン化合物並びにその作製および使用方法
|
|
KR20150016303A
(ko)
|
2012-05-07 |
2015-02-11 |
자프겐 인크. |
6-o-(4-디메틸아미노에톡시) 신나모일 푸마지롤의 옥살레이트 염의 다형체 염 및 이의 제조 및 사용 방법
|
|
BR112014028041A2
(pt)
|
2012-05-08 |
2017-06-27 |
Zafgen Inc |
tratamento de obesidade hipotalâmica com inibidores de metap2
|
|
EP2850079B1
(en)
|
2012-05-09 |
2018-05-02 |
Zafgen, Inc. |
Fumigillol type compounds and methods of making and using same
|
|
JP6169716B2
(ja)
|
2012-11-05 |
2017-07-26 |
ザフゲン，インコーポレイテッド |
肝疾患を治療する方法
|
|
BR112015010223A2
(pt)
|
2012-11-05 |
2017-07-11 |
Zafgen Inc |
compostos tricíclicos para o uso no tratamento e/ou controle de obesidade
|
|
BR112015010225A2
(pt)
|
2012-11-05 |
2017-07-11 |
Zafgen Inc |
compostos tricíclicos e seus métodos de produção e utilização
|
|
EP2968250B1
(en)
|
2013-03-14 |
2019-06-19 |
Zafgen, Inc. |
Methods of treating renal disease and other disorders
|
|
AR105671A1
(es)
|
2015-08-11 |
2017-10-25 |
Zafgen Inc |
Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
|
|
CN106432255A
(zh)
|
2015-08-11 |
2017-02-22 |
扎夫根公司 |
烟曲霉素醇螺环化合物和制备和使用其的方法
|